LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Articles
Cempra Inc.
Headquarters:
Chapel Hill, NC, United States of America
Website:
N/A
Year Founded:
2006
Status:
Merged
BioCentury
|
Aug 23, 2022
Management Tracks
Takeda’s Willemsen becomes CEO at Tessa
Plus new chief business officer at Standigm, and update from Biosion
Read More
BioCentury
|
Dec 17, 2018
Company News
Management tracks: Vertex’s Graney joins Generation Bio
Read More
BioCentury
|
Jun 1, 2018
Financial News
Melinta closes $123.2M follow-on
Read More
BioCentury
|
May 24, 2018
Financial News
Melinta raises $110M in follow-on
Read More
BioCentury
|
Jan 31, 2018
Company News
Management tracks: Ipsen, Dragonfly
Read More
BioCentury
|
Nov 2, 2017
Company News
Management tracks: Melinta, Lundbeck
Read More
BioCentury
|
Aug 11, 2017
Company News
Melinta goes public by acquiring majority of Cempra
Read More
BioCentury
|
Aug 9, 2017
Company News
Melinta goes public by acquiring majority of Cempra
Read More
BioCentury
|
May 19, 2017
Clinical News
Cempra withdraws Solithera MAA
Read More
BioCentury
|
Mar 3, 2017
Clinical News
Oral Solithera: Ph III SOLITAIRE-U data
Read More
Items per page:
10
1 - 10 of 112